Embecta Corp.
A maker of insulin pen needles, syringes, and safety injection devices for people living with diabetes, serving them in more than 100 countries. Its roots trace to 1924, when Becton, Dickinson made the world's first specialized insulin syringe; the business was spun off as its own company in 2022. The name blends "em" for empathy with "bect" from Becton, Dickinson, keeping its century-old heritage while striking out on its own.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| American Century Investment Management, Inc. | 13G/APassive | 0% | 154 | Aug 14, 2026 |
| American Century Companies, Inc. | 13G/APassive | 0% | 154 | Aug 14, 2026 |
| Stowers Institute for Medical Research | 13G/APassive | 0% | 154 | Aug 14, 2026 |
| BlackRock, Inc. | 13G/APassive | 7.7% | 4.55M | Jul 8, 2026 |
| River Road Asset Management, LLC | 13G/APassive | 0% | 0 | May 27, 2026 |
| YACKTMAN ASSET MANAGEMENT LP | 13GPassive | 6.2% | 3.67M | May 5, 2026 |
| AMG YACKTMAN FUND | 13GPassive | 5.07% | 3.00M | May 5, 2026 |
| Vanguard Capital Management | 13GPassive | 5.07% | 3.00M | Apr 29, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 26, 2026 |
| Deerfield Mgmt, L.P. | 13G/APassive | 4.66% | 2.72M | May 13, 2025 |